Order Article Reprints

Cavazzoni A, Digiacomo G, Alfieri R, La Monica S, Fumarola C, Galetti M, Bonelli M, Cretella D, Barili V, Zecca A, et al. Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666. Cancers. 2025; 17(8):1254. https://doi.org/10.3390/cancers17081254

Cavazzoni, Andrea, Graziana Digiacomo, Roberta Alfieri, Silvia La Monica, Claudia Fumarola, Maricla Galetti, Mara Bonelli, Daniele Cretella, Valeria Barili, Alessandra Zecca, and et al. 2025. "Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666" Cancers 17, no. 8: 1254. https://doi.org/10.3390/cancers17081254

Cavazzoni, A., Digiacomo, G., Alfieri, R., La Monica, S., Fumarola, C., Galetti, M., Bonelli, M., Cretella, D., Barili, V., Zecca, A., Giovannetti, E., Fiorentino, M., Tiseo, M., Petronini, P. G., & Ardizzoni, A. (2025). Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666. Cancers, 17(8), 1254. https://doi.org/10.3390/cancers17081254